Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BERNIE: Bevacizumab in Pediatric Metastatic RMS/NRSTS
NCT00643565Phase 2Completed
- Sponsor
- Roche
- Start
- Jul 2008
- Primary completion
- May 2015
- Modality
- Monoclonal Antibodies
- Countries
- 14
01
Overview
A Phase 2 trial of bevacizumab in rhabdomyosarcoma (RMS), non-rhabdomyosarcoma soft tissue sarcoma (NRSTS), sponsored by Roche. Started Jul 2008; status: completed.
02
Drugs
bevacizumab
03
Conditions
rhabdomyosarcoma (RMS)non-rhabdomyosarcoma soft tissue sarcoma (NRSTS)
Beyond the preview
Go deeper on NCT00643565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00643565.